Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development.

导出 OA

翻译打印收藏纠错

作者： Angela Ximena,Argote Camacho ^[1] ; Amanda Rocío,González Ramírez ^[2] ; Alejandro José,Pérez Alonso ^[3] ; Juan David,Rejón García ^[4] ; María Auxiliadora,Olivares Urbano ^[5] ; Pablo,Torné Poyatos ^[6] ; Sandra,Ríos Arrabal ^[5] ; María Isabel,Núñez ^[5]

作者单位： Department of Surgery, Clínico San Cecilio University Hospital, 18012 Granada, Spain. ^[1] Bio-Health Research Foundation of Eastern Andalusia-Alejandro Otero (FIBAO), 18012 Granada, Spain. ^[2] Department of Surgery, Virgen de las Nieves University Hospital, 18014 Granada, Spain. ^[3] Andalusian Tumour Bank Network, 18012 Granada, Spain. ^[4] Department of Radiology and Physical Medicine, University of Granada, 18012 Granada, Spain. ^[5] Department of Surgery and Its Specialties, University of Granada, 18012 Granada, Spain. ^[6] Institute of Biopathology and Regenerative Medicine (IBIMER), University of Granada, 18016 Granada, Spain. ^[7] Biosanitary Research Institute, ibs.Granada, 18012 Granada, Spain. ^[8]

关键词 MMP inhibitors MMPs biomarkers breast cancer diagnostic factors epithelial-to-mesenchymal transition (EMT)extracellular matrix immunohistochemical expression metalloproteinases